Sunday, April 11, 2021
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DARPA Grant to Texas Tech Funds Development of Indoor Airborne Virus Sensor

by Global Biodefense Staff
March 10, 2021
DARPA Grant to Texas Tech Funds Development of Indoor Airborne Virus Sensor

Carbon monoxide is a colorless, odorless gas that can cause headaches, dizziness and even death in certain circumstances. Since this potentially deadly gas is so elusive and dangerous, many homes across the U.S. have carbon monoxide detectors to warn residents of its presence. So, what if that same technology could be used to detect invisible, dangerous and potentially deadly pathogens like pandemic-causing COVID-19?

Gerardine “Gerri” Botte, a professor and Whitacre Department Chair in the Department of Chemical Engineering through Texas Tech University‘s Edward E. Whitacre Jr. College of Engineering, has received a $999,047 grant from the U.S. Department of Defense’s Defense Advanced Research Projects Agency (DARPA) to study just that.

“I have developed a sensor, which we have demonstrated can detect the passing of SARS-CoV-2,” Botte said. “We have done it in saliva and in water, and it’s very fast. It happens within less than a second. In this project, we propose ways to extend the sensor that has worked so well in these media into collecting from air. Ideally, by the time this project concludes, we should be able to develop a prototype that will be tested for determining the presence of SARS-CoV-2 in air.”

The idea behind the project is to develop an indoor COVID-19 sensor, like a carbon monoxide detector, that can detect traces of COVID-19 and other airborne viruses. Knowing if COVID-19 has been detected in a building can help mitigate the spread.

“If you detect it early, you could do surveillance,” Botte said. “You could be able to say, ‘OK, there is a certain contamination in this building,’ then you could potentially close and isolate that building. You could detect something that is coming early enough before it creates an impact. Let’s say the virus was detected in the air in a conference room. You can see who has entered that conference room and immediately put those people in quarantine before they potentially transmit the virus to others.”

The DARPA grant is an accelerated, year-and-a-half program. Botte began working on the project this month and should have results by August 2022.

“This is a very exciting opportunity for us at Texas Tech to get something brand new that has never been done before,” she said. “I’m very excited by the potential implications of this research for our community, for stopping the pandemic, contributing somehow and for the opportunity the graduate students and the postdocs involved in this research are going to have to really work in research that ends in an immediate application, at an accelerated pace.”

More than anything, Botte is excited for the chance for her work at Texas Tech to be part of something much larger.

“If this project becomes like a carbon monoxide detector for the virus, can you imagine the opportunity to have a piece of Texas Tech’s heart everywhere protecting our nation?” Botte said. “That’s what makes me excited, and that’s how I see this project: protecting the world.”

Tags: DARPAEditor PickSensors

Related Posts

New Initiative to Support Studies of the Bat Immune System
Funding News

New Initiative to Support Studies of the Bat Immune System

April 7, 2021
Duke University Develops Portable Diagnostic to Detect Early Biomarkers of Ebola Virus
Biodetection

Duke University Develops Portable Diagnostic to Detect Early Biomarkers of Ebola Virus

April 7, 2021
Technique for Testing Biosensor Materials Could Aid Noninvasive Diagnostic Development
Biodetection

Technique for Testing Biosensor Materials Could Aid Noninvasive Diagnostic Development

March 23, 2021
Texas Biomed Scientists Partner with DoD to Test SARS-CoV-2 Decontamination Technologies
Decontamination

Texas Biomed Scientists Partner with DoD to Test SARS-CoV-2 Decontamination Technologies

March 11, 2021
Load More

Latest News

A Virologist Explains Their Concerns About Coronavirus Variants

A Virologist Explains Their Concerns About Coronavirus Variants

April 8, 2021
What is Thrombocytopenia, the Rare Condition Possibly Linked to the AstraZeneca Vaccine?

What is Thrombocytopenia, the Rare Condition Possibly Linked to the AstraZeneca Vaccine?

April 8, 2021
New Initiative to Support Studies of the Bat Immune System

New Initiative to Support Studies of the Bat Immune System

April 7, 2021
National Vaccine Trial Will Focus on Those with History of Severe Allergies or Mast Cell Disorder

National Vaccine Trial Will Focus on Those with History of Severe Allergies or Mast Cell Disorder

April 7, 2021

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2021 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
  • Subscribe

© 2021 Stemar Media Group LLC